Lisdexamfetamine: Difference between revisions
>KetaKing702 Added it's effect on me (I was diagnosed with ADHD as a kid, which may be related) I recently switched from 4f-mph to lisdexamfetamine and have been experiencing sedation to the point where I nod out at moments, i still experience strong euphoria and everything else besides the energy. It's very enjoyable to me but lacks the simulation and is actually extremely relaxing to me, and I've been on it for a week now and sleep at least 7 hours a night so it's a consistent effect. I just thought I'd... |
>Laxaman US approval history added. |
||
Line 9: | Line 9: | ||
==History and culture== | ==History and culture== | ||
{{historyStub}} | {{historyStub}} | ||
Lisdexamfetamine was developed by New River Pharmaceuticals as a longer-lasting and less-easily abused version of [[Amphetamine#Enantiomers|<small>d</small>-amphetamine]] (dextroamphetamine). <ref name="CNS Spectrums">{{cite journal | vauthors = Mattingly G | title = Lisdexamfetamine dimesylate: a prodrug stimulant for the treatment of ADHD in children and adults | journal = CNS Spectrums | volume = 15 | issue = 5 | pages = 315–325 | date = May 2010 | pmid = 20448522 | doi = 10.1017/S1092852900027541 | s2cid = 46435024 | url = https://digitalcommons.wustl.edu/open_access_pubs/3506 }}</ref> | |||
The FDA approved lisdexamfetamine for ADHD treatment in adults on the 23th of April 2008 <ref name="FDAAdultApproval">{{Cite web|url=http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021977s001ltr.pdf|title=FDA Adult Approval of Vyvanse – FDA Label and Approval History|website=Accessdate.fda.gov|access-date=12 March 2022}}</ref>, followed by an approval binge eating disorder in adults in January 2015. <ref>{{cite press release | title=FDA expands uses of Vyvanse to treat binge-eating disorder | website=U.S. [[Food and Drug Administration]] (FDA) | date=30 January 2015 | url=https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm432543.htm | archive-url=https://web.archive.org/web/20180126103215/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm432543.htm | archive-date=26 January 2018 | url-status=dead | access-date=19 March 2023}}</ref> | |||
==Chemistry== | ==Chemistry== |